Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FY.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FY.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.5.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.5.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.5.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.5.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.5.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.3.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FY.3.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FY.3.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.12ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.12ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.12EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.12EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FR.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FR.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FR.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FR.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FR.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FR.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FR.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FR.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.16.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used